← Back to search

Protein Structures and Oligomeric States

Enter a protein name, UniProt accession or PDB ID. Name searches ask you to confirm the protein identity before related structures are queried.

Current Protein Identity：P30556 New Search
11PDB entries
12Biological assembly
35chain/assembly records
UNP PDB Protein and construct Assembly Composition class Protein state Molecular copy count PDB declaration Consistency status
P30556 4yay Soluble cytochrome b562,Type-1 angiotensin II receptor Author chain A Reference sequence 2–319 1 Insufficient information Monomer Protein 1 monomeric （1） Consistent with protein count
P30556 4zud Chimera protein of Soluble cytochrome b562 and Type-1 angiotensin II receptor Author chain A Reference sequence 2–6 1 Insufficient information Monomer Protein 1 monomeric （1） Consistent with protein count
P30556 4zud Chimera protein of Soluble cytochrome b562 and Type-1 angiotensin II receptor Author chain A Reference sequence 17–315 1 Insufficient information Monomer Protein 1 monomeric （1） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 227–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain B Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain B Reference sequence 227–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 2–226 2 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 227–319 2 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain B Reference sequence 2–226 2 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6do1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain B Reference sequence 227–319 2 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 6os0 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 6os0 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 227–319 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 6os1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 6os1 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 227–319 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 6os2 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 6os2 Type-1 angiotensin II receptor,Soluble cytochrome b562 BRIL fusion protein Author chain A Reference sequence 227–319 1 Insufficient information Heteromer Protein 3 trimeric （3） Consistent with protein count
P30556 8th3 AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 8th3 AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex Author chain A Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 8th3 AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex Author chain B Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 8th3 AT118-H nanobody, Type-1 angiotensin II receptor, Soluble cytochrome b562 complex Author chain B Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 8th4 Type-1 angiotensin II receptor Soluble cytochrome b562 complex Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 8th4 Type-1 angiotensin II receptor Soluble cytochrome b562 complex Author chain A Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eah Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eah Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eah Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eah Nanobody AT209,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eai Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eai Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eai Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eai Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eaj Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eaj Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain A Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eaj Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 2–226 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count
P30556 9eaj Nanobody AT206,Type-1 angiotensin II receptor,Soluble cytochrome b562 Author chain B Reference sequence 235–319 1 Insufficient information Heteromer Protein 4 tetrameric （4） Consistent with protein count

“Homomeric versus heteromeric classification follows protein identity; different constructs of the same UniProt entry still require comparison of reference-sequence ranges, mutations and missing segments. Assemblies marked for review remain visible but are not included in the highest-confidence candidate set.